Rodrigo Flores-Espinoza

Dr. Rodrigo Flores-Espinoza

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CFCamila Alexandra Farinango
Camila Alexandra Farinango
JGJennifer Nicole Gallardo
Jennifer Nicole Gallardo
BFByron Freire-Paspuel
Byron Freire-Paspuel
RFRodrigo Flores-Espinoza
Rodrigo Flores-Espinoza
GJGABRIELA Jaramillo-Koupermann
GABRIELA Jaramillo-Koupermann
Alejandro Cabrera-AndradeAlejandro Cabrera-Andrade
Alejandro Cabrera-Andrade
Dihydropyrimidine dehydrogenase is one of the main pharmacological metabolizers of fluoropyrimidines, a group of drugs widely used in clinical oncology. Around 20 to 30% of patients treated with fluoropyrimidines experience severe toxicity caused by a partial or total decrease in enzymatic activity. This decrease is due to molecular variants in the DPYD gene. Their prevalence and allelic frequencies vary considerably worldwide, so their description in heterogeneous groups such as the Ecuadorian population will allow for the description of pharmacogenetic variants and proper characterization of this population. Thus, we genotyped all the molecular variants with a predictive value for DPYD in a total of 410 Ecuadorian individuals belonging to Mestizo, Afro-Ecuadorian, and Indigenous ethnic groups. Moreover, we developed a genetic ancestry analysis using 46 autosomal ancestry informative markers. We determined 20 genetic variations in 5 amplified regions, including 3 novel single nucleotide variants. The allele frequencies for DPYD variants c.1627G>A (*5, rs1801159), c.1129-15T>C (rs56293913), c.1218G>A (rs61622928), rs1337752, rs141050810, rs2786783, rs2811178, and g.97450142G>A (chr1, GRCh38.p13) are significantly related to Native American and African ancestry proportions. In addition, the FST calculated from these variants demonstrates the closeness between Indigenous and Mestizo populations, and evidences genetic divergence between Afro-Ecuadorian groups when compared with Mestizo and Indigenous ethnic groups. In conclusion, the genetic variability in the DPYD gene is related to the genetic component of ancestral populations in different Ecuadorian ethnic groups. The absence and low frequency of variants with predictive value for fluoropyrimidine toxicity such as DPYD *2A, HapB3, and c.2846A>T (prevalent in populations with European ancestry) is consistent with the genetic background found.

25 June 2021 in American Journal of Physical Anthropology
Verified
Journal Article
Closed access
PDF file
RFRodrigo Flores-Espinoza
Rodrigo Flores-Espinoza
EPElius Paz‐Cruz
Elius Paz‐Cruz
VRViviana A. Ruiz‐Pozo
Viviana A. Ruiz‐Pozo
MLMarcelo Lopez‐Carrera
Marcelo Lopez‐Carrera
Alejandro Cabrera-AndradeAlejandro Cabrera-Andrade
Alejandro Cabrera-Andrade
GBGermán Burgos
Germán Burgos

1 December 2019 in Forensic Science International: Genetics Supplement Series
Verified
Journal Article
Closed access
GBGermán Burgos
Germán Burgos
RFRodrigo Flores-Espinoza
Rodrigo Flores-Espinoza
VRV.A. Ruiz-Pozo
V.A. Ruiz-Pozo
IGI. Villacrés Granda
I. Villacrés Granda

1 December 2019 in Forensic Science International: Genetics Supplement Series
Verified
Journal Article
Open access
GBGermán Burgos
Germán Burgos
FSF. Simão
F. Simão
RFRodrigo Flores-Espinoza
Rodrigo Flores-Espinoza
JYJ.I. Yepez-Santos
J.I. Yepez-Santos
AGA. Garzón-Salazar
A. Garzón-Salazar
LGLeonor Gusmão
Leonor Gusmão